NASDAQ : LNSR
LENSAR, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.8 USD (Oct 30, 2026, 3:27 PM EDT) · Market cap 71.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 70.03M |
| Enterprise Value | 58.85M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 12.29M |
| Shares Outstanding | 12.29M |
| Shares Change (YoY) | +53.73% |
| Shares Change (QoQ) | +49.33% |
| Owned by Insiders (%) | 19.07% |
| Owned by Institutions (%) | 36.24% |
| Float | 8.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 10.74 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| Forward PS | 1.05 |
| PB Ratio | 4.81 |
| P/TBV Ratio | 6.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 4.00 |
| EV / Sales | 0.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.39 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 357.30% |
| Return on Assets (ROA) | -18.66% |
| Return on Invested Capital (ROIC) | -108.24% |
| Return on Capital Employed (ROCE) | -41.86% |
| Weighted Average Cost of Capital (WACC) | 9.14% |
| Revenue Per Employee | $401,760 |
| Profits Per Employee | $98,000 |
| Employee Count | 150 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.41 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -54.07% |
| 50-Day Moving Average | 7.04 |
| 200-Day Moving Average | 7.42 |
| Relative Strength Index (RSI) | 30.67 |
| Average Volume (20 Days) | 39,896 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 306,972 |
| Short Previous Month | 322,414 |
| Short % of Shares Out | 2.50% |
| Short % of Float | 3.47% |
| Short Ratio (days to cover) | 6.64 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 60.26M |
| Gross Profit | 29.13M |
| Operating Income | -20.90M |
| Pretax Income | 34.70M |
| Net Income | 14.70M |
| EBITDA | -16.33M |
| EBIT | -20.90M |
| Earnings Per Share (EPS) | $0.53 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.57M |
| Total Debt | 2.38M |
| Net Cash | 11.18M |
| Net Cash Per Share | $0.91 |
| Equity (Book Value) | 28.69M |
| Book Value Per Share | 1.21 |
| Working Capital | 27.39M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.29M |
| Capital Expenditures | -35,000 |
| Depreciation & Amortization | 4.57M |
| Net Borrowing | -10.00M |
| Free Cash Flow | -7.33M |
| FCF Per Share | -$0.60 |
Margins
| Measure | Value |
|---|
| Gross Margin | 48.34% |
| Operating Margin | -34.68% |
| Pretax Margin | 57.57% |
| Profit Margin | 57.57% |
| EBITDA Margin | -27.09% |
| EBIT Margin | -34.68% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -53.73% |
| Shareholder Yield | -53.73% |
| Earnings Yield | 9.31% |
| FCF Yield | -10.46% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $11.33 |
| Price Target Difference | 98.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 17.00% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.64 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |